KPI-012 ophthalmic solution

· Combangio, Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KPI-012 ophthalmic solution, covering 2025-10-22 to 2025-10-22. Get the full timeline:

Most recent: Clinical Trial Update: Trial to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With PCED [Phase 2]